chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Period length has increased by 4 additional days every month since receiving vaccine.  I spot / bleed for two additional days before and two additional days after my period than I did before having the vaccine.
On afternoon at 11-12-10 developed fever (as high as 101 degrees oral), malaise, body aches, and skin induration. These symptoms lasted about 48 hours, but still has area of Lt. upper arm 12.5cm long and 12 cm wide that is red, indurated.
The evening of my second dose, when getting into bed with the lights off, I noticed bright lights flashing out of my right eye.   I still notice this including today.  On Mar 25th, I called a college friend, Dr. , a Retinal Surgeon, and described my symptoms.  He suggested it would be prudent that I have this routinely checked out.  He suggested a facility with an Optos scanner.  On March 29th, I visited my usual optometrist, at facility, and had an exam, with this test, an with my eyes dialtated.  He diagnosed Posterior Vitreous Detachment (PVD).  I realize this could be a coincidence, but feel it is appropriate to report this as I first noticed it the night of my second vaccination.
Information has been received from an 18 year old  female who in 2007 was vaccinated IM with a dose of Gardasil. The patient reported that she is 8 weeks pregnant and received the vaccine. No adverse reaction reported. Follow up information has been received from a physician concerning the 18 year old female with 0 previous pregnancies and no medical history who on 04-JUN-2007 was vaccinated IM with a dose of Gardasil. The patient received an elective abortion at 8 weeks. The elective termination occurred the week of 04-JUN-2007. Upon internal review, elective abortion was considered to be an other important medical event. No further information is available.
Patient received an undiluted dose (0.2ml) of the Pfizer children's 5-11.  Patient stayed with guardian in the pharmacy for 15-20 minutes with parent and no reactions were noted; patient left.  Market manager stated she will follow up with parent.
Saw patient the day after his second Covid 19 vaccine and he had an elevated temperature of 101.3 F.  No other adverse symptoms.  No sediment in his urine, no abnormal amounts of discharge from Tracheostomy site, lungs clear, no infections from any wounds.
UTI; patient on antibiotics; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI) and ANTIBIOTIC LEVEL (patient on antibiotics) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (UTI) and ANTIBIOTIC LEVEL (patient on antibiotics). The patient was treated with CIPROFLOXACIN for Urinary tract infection, at a dose of 500 mg twice a day. At the time of the report, URINARY TRACT INFECTION (UTI) and ANTIBIOTIC LEVEL (patient on antibiotics) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided The patient reported UTI and the patient received a first round of antibiotic for 5 days, patient UTI was not covered in the first prescription of antibiotics.
Bad effects from second shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Bad effects from second shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Bad effects from second shot). At the time of the report, VACCINATION COMPLICATION (Bad effects from second shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter.  Treatment details was not reported by the reporter.
This spontaneous report as received from a medical assistant refers to a 12-month-old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not provided. On 16-SEP-2021, the temperature went out of range in the freezer where the vaccines were stored. The vaccine was taken to the hospital freezer with half an hour of temperature out of range. The freezer was replaced, and the vaccines were stored in the new freezer, 7 days after freezer temperature was controlled. On 22-OCT-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose 1, subcutaneously in the right leg; lot number reported as 0002534 expiration date 24-JUL-2022) for prophylaxis. Lot number 0002534 is an invalid lot number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II). Lot number 0002534 does not match any Company product as confirmed by Lot Verification team.
When he took off the band aid there was a blister under the band aid; towards the edge, not on the injection site.; The blister has popped and the area is red; Received Pfizer Covid 19 Vaccine Booster after one dose of Johnson and Johnson Covid Vaccine; Received Pfizer Covid 19 Vaccine Booster after one dose of Johnson and Johnson Covid Vaccine; This is a spontaneous report from a contactable consumer or other non hcp (patient's wife). A 48-years-old male patient received bnt162b2 (COMIRNATY, solution for injection, Lot number was not reported), via an unspecified route of administration on 04Nov2021 (at the age of 48 years) as dose 2 (booster), single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient illness at time of vaccination was none.  The patient received steroid injection in hip 2 weeks prior to Pfizer Covid Vaccine. Historical vaccine included Johnson and Johnson Covid 19 Vaccine on 07Apr2021 for covid-19 immunization, Lot Number: Provided as being either 042A21A or 042AZ1A and flu vaccine 2 weeks prior to Pfizer covid vaccine on Oct-21. On 05Nov2021, the patient experienced "when he took off the band aid there was a blister under the band aid; towards the edge, not on the injection site, the blister has popped and the area is red, received pfizer covid 19 vaccine booster after one dose of johnson and johnson covid vaccine on 04Nov2021. The area is red and is wondering if this is a normal side effect. Caller stated that she has no information available for the Pfizer Covid 19 Vaccine booster that her husband received yesterday.  She does not have the NDC, Lot Number, or Expiry Date. She reported that her husband's previous Covid 19 Vaccine was the Johnson and Johnson Vaccine.  Her husband was told that he could go ahead and get the Pfizer Vaccine as his booster. Event did not cause Emergency Room or Physician Office visit. Clinical outcome of the events was reported as unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Pt. c/o itchiness, hands swollen, low grade fever, sore throat and general not feeling well within 1 1/2 hours of injection. Took BENADRYL at home.
Papulovesicular lesions to skin increasing x 2 da.  Pt. diagnosed with varicella.
full body hives treated with Benadryl and hydrocortisone (topical)  resolution starting on day 3, air way concerns but face was affected (swelling/itchiness)
Case number PHEH2014US021615 is an initial spontaneous report received from a pharmacist on 24 Oct 2014. This report refers to a 40 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 1412001) intramuscularly on 07 Oct 2014. It was reported that on the same day shortly after vaccination, she started experiencing hives all over her body, low grade fever, pain and swelling at the vaccination site and pain in her joints. She went to emergency room for the symptoms and also visited her personal MD on 24 Oct 2014. The events outcome was reported as unknown. The seriousness of the event was not reported, but was upgraded internally based on information available in the source documents. The causality of the events was not reported.
side affects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side affects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side affects). At the time of the report, VACCINATION COMPLICATION (side affects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication history not provided. Treatment information was unknown.
delayed reaction at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (delayed reaction at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE REACTION (delayed reaction at the injection site). At the time of the report, INJECTION SITE REACTION (delayed reaction at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Reporter states that her friend is a nurse and had the same delayed reaction at the injection site as her and states that it's a delayed immune response to the vaccine.
Information has been received from a physician concerning a 63 female who on 27-DEC-2007 was vaccinated with a single dose of ZOSTAVAX (lot#: 656609/0015U). On 10-JAN-2008, the patient developed a mild case of shingles. There were blisters underneath one breast. The outcome of the shingles was not reported. The patient sought unspecified medical attention. Additional information has been requested.
16NOV98 mom called & stated child caught chickenpox from shot given 5NOV98;sx started 13NOV98 mild fever;14NOV98 lethargic but went to dad house;
blood pressure 75/60 pulse 132 fainted dizziness weakness arm pain.added fluids still alive
Approximately 2-2.5 hours after injection, experienced moderate chills.  Despite 3-4 layers of clothing worn in a room temperature home, I ended up under blankets, still shivering.  Chills lasted approx. 5 hours, then resumed again at lesser intensity about 4 hours later and lasted about an hour that time.  Next day, moderate fatigue and body aches which lasted all day.  Minor relief from NSAID (2 Advil).  No further chills or aches, but currently experiencing mild metallic taste noticeable when eating, which mirrored shot #1 side effect (that metallic taste was stronger and beside fatigue, was my only side effect for shot #1 (also reported here earlier)).
Eyelid edema, ? tongue swelling. Rx: Epinephrine, Benadryl, Prelone.
Beginning night of shot headache, body aches, chills, fever, nausea, arm stiffness. "Sore skin, like skin sensitivity." Took Tylenol 1,000mg, and Pepto. Patient reported some mild relief of nausea after taking Pepto.
Rash on stomach, arm , hairline since 9/26 fluid filled, itchy
Patient had a heart attack two days after receiving first Covid Vaccine.  Doctor reports that artery was 99% blocked.
Knee replacement; This spontaneous case was reported by a consumer and describes the occurrence of KNEE ARTHROPLASTY (Knee replacement) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (First Pfizer Primary monovalent dose), PFIZER BIONTECH COVID-19 VACCINE (3rd Pfizer dose) and PFIZER BIONTECH COVID-19 VACCINE (2nd Pfizer Primary monovalent dose). Past adverse reactions to the above products included No adverse reaction with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 24-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2022, the patient experienced KNEE ARTHROPLASTY (Knee replacement). At the time of the report, KNEE ARTHROPLASTY (Knee replacement) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.   This case was linked to MOD-2023-726953 (Patient Link).
Patient tested positive for Covid-19 on 2/2/2022 and passed away on 6/30/2022 from acute on chronic respiratory failure.
headache; her head was dizzy; her hands were numb; she was seeing blurry; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 24 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 07Sep2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DIZZINESS (non-serious) with onset 2021, outcome "recovered" (2021), described as "her head was dizzy"; HYPOAESTHESIA (non-serious) with onset 2021, outcome "recovering", described as "her hands were numb"; VISION BLURRED (non-serious) with onset 2021, outcome "recovered" (2021), described as "she was seeing blurry"; HEADACHE (non-serious), outcome "unknown", described as "headache". Therapeutic measures were taken as a result of dizziness, headache. It was unknown if therapeutic measures were taken as a result of hypoaesthesia, vision blurred. Additional Information: The patient stated that she took Tylenol for the headache and for the dizziness she used some ethanol alcohol. It was reported that patient taking probiotics at the time, they were started a week before taking the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a licensed practical nurse concerning a patient who was vaccinated with a dose of VARIVAX (Merck). The patient developed rash on the body after receive the VARIVAX (Merck). Follow up information received on 08-May-2009 from the licensed practical nurse stating that this was the patient's second dose of VARIVAX (Merck). She did not remember the patient so she was unable to provide further information. The LPN stated that this was over a period of time and did not believe that the other patient's involved (WAES 0905USA00016 and 0905USA00488) were vaccinated with the same vaccine lot number. This is one of three reports from the same source. Additional information has been requested.
pt recvd vax 3SEP87 & 15FEB91 dx w/flu characterized by bronchitis, diarrhea & temp; in addtl exp vomiting, congestion, stomach ache, oral candidiasis, swollen facew/rash, fever, cough, eye discharge, difficulty breathing, & measles;
Participant presented with chronic episodic cough the most recent having lasted since 14 Apr 2022 before admission. The Participant is a 33-year-old Female G6 P5+0 who at the time of hospitalisation or admission on 16 Jun 2022 was diagnosed with severe pneumonia in pregnancy. The participant reported a history of chronic intermittent productive cough the cough was first picked during surveillance on 14 Apr 2022 However during her hospitalization there were discrepant durations of this cough documented. There was no associated fever or other symptoms like weight loss or night sweats however the participant had chest pain and difficulty in breathing and or fast breathing. She is vaccinated with 2 doses of Moderna vaccine. first dose was on 21 Feb 2022, the second dose was received on 21 Mar 2022. Her baseline viral load at study entry on 21 Feb 2022 was 777 cp/ml. Remarkable findings at admission were respiratory findings of Tachypnoea 25 breaths per minute, supraclavicular recession, and coarse crepitations right mammary area. Other complaints during this hospitalization included a whitish Per vaginal discharge with urgency and frequency. Past obstetric history was unremarkable with all 5 deliveries by Spontaneous vertex delivery. Past medical and surgical history was unremarkable apart from being a youth perinatally infected with HIV, stable on her current treatment. No past Tuberculosis diagnosis or treatment. The Participant remained saturated at 95-96%. However, the participant was tachypneic at a rate of 32-34, BPs remained between 110/60 to 98/60 while admitted. Obstetric examination: fundal height was 24/40 weeks. Other systems examined were within normal limits. EDD BY LNMP:05 OCT  2022,BY ULTRASOUND 06 OCT 2022. Diagnosis with differentials at admission was severe pneumonia ruling out possible:- ? Pulmonary tuberculosis,  ? COVID -19, ? Pneumocystis Jiroveci Pneumonia, ? Pleural Effusion.   Medication received during hospitalisation is:- I.V ceftriaxone 1 g o.d then 2g o.d, Tabs fefol 1-tab o.d tabs cotrimoxazole 960mg o.d ART Tenofovir disoproxil fumarate/lamivudine/dolutegravir 1 tablet o.d
pt recv vax 29APR99 & 1min later had episode of shaking or tonic clonic movement of rt arm lasting 10-15sec;briefly sleepy thereafter & slept more than usual next 24hr;
Started with swelling  to lower half of body, huge blisters on feet,  confusion, dizziness, hallucinations. With in 2 weeks in hospital fighting for his life in heart, kidney and liver failure.
patient has not experienced any adverse reactions; Pharmacist stated an expired PNEUMOVAX 23 vaccine was accidentally given to a patient; This spontaneous report was received from a pharmacist referring to a male patient in his 50's. The patient's medical history, concurrent condition and concomitant therapy were not provided.  On 28-AUG-2020, the patient was accidentally vaccinated with an expired pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot# S004548, expiration date 12-AUG-2020; dose detail, strength and route were not provided) in the left arm for prophylaxis (expired product administered).  The patient had not experienced any adverse reactions related to the expired vaccine administered. The outcome of expired product administered was unknown. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S004548; expirationdate: 12-AUG-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Was originally scheduled for a treadmill stress test due to chest pain that began PRIOR to receiving the 3rd dose. That test resulted in an abnormal stress echocardiogram. Chest pain was different after test, and since the results were abnormal, they  sent me for a stress MRI, which also yielded abnormal results.
Fixed Drug Eruption - Information has been received from a physician concerning a 22 month old caucasian male patient with Krb's palsy who on 17 Nov 1999 was vaccinated in the right arm with a first dose of varicella virus vaccine live (lot 631773/1033j.  On 21 Mar 2000 the patient broke out with chickenpox.  The patient is not yet recovered. Follow up information from a physician noted that after the patient was seen in the physician's office on 23 Mar 2000 it was determined that the rash reported was not due to varicella virus vaccine live but was a fixed drug eruption secondary to amoxicillin.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, 4 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the wife of patient. The age at vaccination was not reported. The patient got shingles 4 days after the SHINGRIX was administered. The reporter asked could SHINGRIX cause shingles.
warm, localized itching-appeared swelling/mild until sleeve which was rolled up & tight, was lowered & cool pack applied, this resolved;some mild itching top  of head w/inc BP common 160/120, which dec 5min to 160/94, HR 86 reg;
Fever; Chills; Joint pain; Strange dreams; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received his first dose of bnt162b2 (BNT162B2 reported as Pfizer COVID vaccine and as Coronavirus Vaccine; unknown lot number and expiration date), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that he has a student who verbally informed that he was unable to attend class on 19Jan2021 because of his concern of the adverse events from the first vaccine. It was reported that he should take second dose on or around 19Jan2021. The patient experienced fever, chills, joint pain and strange dreams on an unspecified date. He does not have any other information except the list of adverse events that he is experiencing. The outcome of the events was unknown.   The following information on the batch/lot number has been requested.
Had joint ache evening of vaccination.  Resolved overnight.  Next day (4/12/2021) had mild muscular ache in the morning.  Resolved morning of 4/13/2021.
History of Present Illness: Patient is a 53y.o. male with a PMHx of hypertension that is being evaluated for bilateral lower extremity edema. Patient presented to emergency department on 12/15 for worsening bilateral lower extremity edema for the past week. He works at a cash register at store and spends most of the time on his feet. He first noticed the swelling after working a few shifts and started to experience pain in the bilateral feet with the swelling. The pain was described as a severe, sharp pain in the feet and ankles. He reports almost passing out due to the pain. He was tried on Lasix for the swelling by his PCP, which did not improve the edema. He is hardly able to walk due to the pain. He denies any shortness of breath, palpitations, lightheadedness, dizziness, or orthopnea. He denies any chest pain, pressure, or tightness. The patient is fully vaccinated against covid-19, but tested positive on arrival to the ED. He denies any cardiac history. He does not take any home medications for his history of hypertension. In the ED, vital signs were showed a HR 108. Labs BNP 175, troponins were negative. CXR showed no acute process.